Editorial: Third Covid wave raises questions over antiviral drugs
OPINION: Our editorial on treatment options for Covid infections.
AdvertisementAdvertise with NZME.
Latest fromPharmac
'An early Christmas gift': Life-changing drug to get public funding
Pharmac has reached a provisional agreement with medicine supplier Vertex to fund Trikafta
Cystic fibrosis: Funding of life-extending drug Trikafta proposed to start in April
Funding of Trikafta will be for those aged 6 and older who meet certain criteria.
Vaccination programme must target Māori and Pacific, say advocates
Health workers want meningococcal vaccination to be more widely available.
Meth access cutting demand for abuse of ADHD medications - GP's lawyer
It is alleged the GP wrote ADHD medication prescriptions without specialist approval.
'Cruel and heartless': $52k annual tax on 'miracle drug' slammed
'We will do anything to keep our boy alive but ... detest having to pay tax to do so.'
'We still wait, and die, for our miracle drug - why?'
OPINION: 'Trikafta makes cystic fibrosis a manageable condition. It lets people live.'
Should cancer drugs be GST-free? Patient who has spent $200k to survive says yes
"I still feel I've got everything going for me," the 76-year-old says.
'Biggest change in a lifetime': ADHD healthcare improvements on the table
'This is a giant step forward. It's just unbelievable.'
Cystic fibrosis: Pharmac receives updated advice for funding Trikafta
Pharmac has re-ranked Trikafta on its Options for Investment list after updated advice.
Pharmac 'procrastinating' over funding glucose monitors
Glucose monitors would be life-changing for all with diabetes.
'Worst fears come true': Why NZ is not ready for a fentanyl crisis
Low doses of the life-saving antidote Naloxone are a worry, says NZ Drug Foundation.
Explainer: End of DHBs - what you need to know about new system
The focus has been on the top end of the planned changes - what about the local level?
Pharmac HIV treatment change should give patients more privacy
HIV prevention group happy but campaigner says work needed on cancer, rare illnesses.
'What Pharmac has in common with the Reserve Bank'
OPINION: What New Zealand has done with both entities is forget history.
Watch: Pharmac review uncovers 'systemic failings' for those with rare disorders
People with rare disorders facing excessive suffering under Pharmac model, review finds.
Mystery donor: $27K 'miracle drug' couriered to Rotorua teen with cystic fibrosis
The anonymous sender wrote: 'Keep fighting hard - you've got this. I hope this helps.'
'For some of us it is a life-and-death decision': Pharmac boost not enough, patients say
Ill patients say lack of Budget funding for new drugs means some of them will die sooner.
Budget 2022: 10 key things - Where the money's gone
Here are the highlights as Grant Robertson announces the Government's plans.
Cancer drug debate: Give Pharmac more funds, Greens say
Cancer drugs, mental health support system in spotlight ahead of Budget.
Opinion: If we are serious about cancer, we need to fund more drugs
There are 18 cancer treatments publicly funded in Australia that aren't available here.
'It saves lives': Kristie Purton could still be alive if Trikafta was available
The second 'Cystic Sister' died in 2019 from cystic fibrosis.
Health reforms review divided over Māori role
The special committee examining the Govt's health reforms has completed its final report.
'He is dying': Tearful mother faces losing second child
But a 'miracle drug' she can't afford could save him.
Two brothers have the same condition. But only one can get $330k 'miracle' drug
One brother says it's a 'kick in the guts' knowing he could not get the drug.
Kathy Spencer: Pharmac review - what to look for
OPINION: Why the impending release of a review of Pharmac matters so much right now.
South Auckland GPs call for new anti-viral drugs
Almost 50 per cent of all current Covid-19 cases in NZ are in Counties Manukau district.
Medicinal cannabis drastically improving eight-year-old's life
Taupō family fundraising for life-changing cannabis medicine that costs $700 a month.
Covid 19 drug to stay in New Zealand for now
Ronapreve was used to fight Delta, but its effectiveness against Omicron is unknown.
Essential medications rationed due to supply shortages
Essential medications rationed, supplies short, pharmacists cancel maternity leave.
Watch: Experts explain 'gamechanger' treatments for Covid
They've been described as "gamechangers" in the fight against Covid-19.
Live: Experts warn 'race is on' as new Covid drug set for NZ
In high risk patients it can reduce the risk of death and hospitalisation by 89 per cent.
'Damning' Pharmac report reveals 'fortress mentality' to decision-making
It also questions commitments to equity; just four of its nearly 150 staff are Māori.
First wahine Māori to head Pharmac advisory board
Dr Jane Thomas to lead Pharmacology and Therapeutics Advisory Committee from December.